Benzinga | Aug 31, 2021 08:24AM EDT

BTIG Maintains Buy on Abbott Laboratories, Raises Price Target to $136

BTIG analyst Marie Thibault maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $126 to $136.